Are all P2Y12 equally effective in vein graft angioplasty? A report from the UK database

Are all P2Y12 equally effective in vein graft angioplasty? A report from the UK database

Key Points Information of P2Y12 inhibitors in acute coronary syndromes with vein graft angioplasty is limited. This new analysis from the UK database was not able to find significant differences between Clopidogrel, Prasugrel and Ticagrelor. Large trials would be needed to reliably confirm the best...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Catheterization and cardiovascular interventions 2018-10, Vol.92 (4), p.666-667
Hauptverfasser: Berladi, Jorge, Lamelas, Pablo M.
Format: Artikel
Sprache:eng
Schlagworte:
Acute Coronary Syndrome
Angioplasty
Clopidogrel
Humans
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Prasugrel Hydrochloride
United Kingdom
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Key Points Information of P2Y12 inhibitors in acute coronary syndromes with vein graft angioplasty is limited. This new analysis from the UK database was not able to find significant differences between Clopidogrel, Prasugrel and Ticagrelor. Large trials would be needed to reliably confirm the best antiplatelet regimen in this setting.
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.27909